Neuronetics Inc. (NASDAQ:STIM) saw a downside of -17.97% to $5.25 after subtracting -$1.15 on Wednesday. The 5-day average trading volume is 421,634 shares of the company’s common stock. It has gained $6.67 in the past week. An average of 391,449 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 439,397.
STIM’s 1-month performance is -5.88% or -$1.66 on its low of $4.66 reached on 10/13/21. The company’s shares have touched a 52-week low of $4.78 and high of $22.43, with the stock’s rally to the 52-week high happening on 01/22/21. YTD, STIM has lost -42.39% or -$5.97. However, the current price is down -76.59%% from the 52-week high price.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
On Jul 28, 77 days have gone by since the last insider trading activity for Neuronetics Inc. (STIM). Furlong Stephen (CFO) most recently sold 6,563 shares at $13.08 per share on Jul 28. This transaction cost the insider $85,844. President and CEO, Sullivan Keith J, sold 93 shares at a price of $13.64 on Jul 16. Then, on Jul 15, President and CEO Sullivan Keith J sold 50,893 shares at a price of $13.46 per share. This transaction amounted to $684,913.
Neuronetics Inc. (STIM) has a trailing price-to-earnings (P/E) ratio of 26.50 for the broader industry and 32.24 for the sector.STIM stock has a beta of 2.49. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 3.18 while the price-to-book (PB) in the most recent quarter is 1.71.
Neuronetics Inc.’s quick ratio for the period ended June 29 was 11.20, with the current ratio over the same period at 11.60 meaning that STIM stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.36, while the total debt to equity was 0.36. In terms of profitability, the gross margin trailing 12 months is 79.10%. The trailing 12-month EBITDA margin is -43.39% while for the period ending June 29; Neuronetics Inc.’s operating margin was -34.10%. The firm’s gross profit as reported stood at $37.69 million against revenue of $49.24 million.
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 6.59% to $12.29 million, while revenue of $15.58 million was -26.77% off the previous quarter. Analysts expected STIM to announce -$0.24 per share in earnings in its latest quarter, but it posted -$0.29, representing a -20.80% surprise. EBITDA for the quarter stood at more than -$6.29 million. STIM stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 50.93 million, with total debt at $38.48 million. Shareholders hold equity totaling $26.32 million
Let’s look briefly at Neuronetics Inc. (STIM) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 24.13% to suggest the stock is trending oversold, with historical volatility in this time period at 112.79%.
The stock’s 5-day moving average is $6.16, reflecting a -19.28% or -$1.23 change from its current price. STIM is currently trading -21.50% above its 20-day SMA, -65.09% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -31.99% and -55.09% respectively.
Stochastic %K and %D was 31.38% and 39.46% and the average true range (ATR) pointed at 0.51. The RSI (14) points at 28.33%, while the 14-day stochastic is at 21.98% with the period’s ATR at 0.51. The stock’s 9-day MACD Oscillator is pointing at -0.35 and -0.43 on the 14-day charts.
In the most recent analyst report for Neuronetics Inc. (NASDAQ: STIM), BTIG Research downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for STIM stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate STIM as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 4 have offered a “buy” rating.
What is STIM’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $12.00 and a high of $18.00, with their median price target at $15.00. Looking at these predictions, the average price target given by analysts is for Neuronetics Inc. (STIM) stock is $15.00.